Akeso, Inc. (AKESF)
OTCMKTS · Delayed Price · Currency is USD
12.81
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
Akeso Market Cap
Akeso has a market cap or net worth of $12.4 billion as of February 11, 2026. Its market cap has increased by 83.03% in one year.
Market Cap
12.40B
Enterprise Value
12.02B
Revenue
350.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
$12.81
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 2.39B to 12.40B, an increase of 418.11%. That is a compound annual growth rate of 32.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 12.40B | -7.31% |
| Dec 31, 2025 | 13.37B | 90.66% |
| Dec 31, 2024 | 7.01B | 40.41% |
| Dec 29, 2023 | 5.00B | 7.71% |
| Dec 30, 2022 | 4.64B | 30.19% |
| Dec 31, 2021 | 3.56B | -7.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 406.62M |
| CytoDyn | 317.38M |
| Silence Therapeutics | 224.36M |
| Vaxart | 145.67M |
| HST Global | 139.70M |
| BioStem Technologies | 104.83M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |